Mucopolysaccharidosis type VII in a German Shepherd Dog

Journal of the American Veterinary Medical Association

Volumn 224, Issue 4, 2004, Pages 553-557+532

  Silverstein Dombrowski, Deborah C ^a,b   Carmichael, K Paige ^b   Wang, Ping ^a   O'Malley, Thomas M ^a   Haskins, Mark E ^a   Giger, Urs ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; DOG DISEASE; HISTOPATHOLOGY; MUCOPOLYSACCHARIDOSIS TYPE 7; NEUTROPHIL; NONHUMAN; SPINE RADIOGRAPHY; VERTEBRA;

ANIMALS; BREEDING; DOG DISEASES; DOGS; GENETIC SCREENING; GLUCURONIDASE; MALE; MUCOPOLYSACCHARIDOSIS VII; MUTATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 1142274392     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.553     Document Type: Article

References (29)

1. Haskins ME, Giger U. Lysosomal storage diseases. In: Kaneko JJ, Harvey JW, Bruss ML, eds. Clinical biochemistry of domestic animals. 5th ed. San Diego: Academic Press Inc, 1997;741-760.
2. Schuchman EH, Toroyan TK, Haskins ME, et al. Characterization of the defective beta-glucuronidase activity in canine mucopolysaccharidosis type VII. Enzyme 1989;42:174-180.
3. Gao CH, Sands MS, Haskins ME, et al. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice. Mol Ther 2000;2:233-244.
4. Sammarco C, Weil M, Just C, et al. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII. Bone Marrow Transplant 2000;25:1289-1297.
5. Haskins ME, Desnick RJ, Diferrante N, et al. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis II, VI, VII. Pediatr Res 1984;18:980-984.
6. Ray J, Bouvet A, DeSanto C, et al. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells. Genomics 1998;48:248-253.
7. Ponder KP, Melniczek JR, Xu L, et al. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A 2002;99:13102-13107.
8. Skelly BJ, Franklin RJ. Recognition and diagnosis of lysosomal storage diseases in the cat and dog. J Vet Intern Med 2002;16:133-141.
9. Giger U, Casal ML, Ellinwood M, et al. Lysosomal storage diseases, in Proceedings. 10th Cong Int Soc Anim Clin Biochem 2002;41-46.
10. King LW, Alroy J. Intracellular and extracellular depositions: Degenerations. In: Jones TC, Hunt RC, King NW, eds. Veterinary pathology. 5th ed. Baltimore: The Williams & Wilkins Co, 1997;25-57.
11. Jolly RD, Walkely SU. Lysosomal storage disease of animals: an essay in comparative pathology. Vet Pathol 1997;34:527-548.
12. Haskins M, Casal M, Ellinwood NM, et al. Animal models for mucopolysaccharidoses and their clinical relevance. Acta Pediatr 2002;91:S88-S97.
13. Glew RH, Basu A, Prence EM, et al. Biology of disease: lysosomal storage diseases. Lab Invest 1985;53:250-269.
14. Fyfe JC, Kurzhals RL, Lassaline ME, et al. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII. Genomics 1999;58:121-128.
15. Gitzelmann R, Bosshard NU, Superti-Furga A, et al. Feline mucopolysaccharidosis VII due to beta-glucuronidase deficiency. Vet Pathol 1994;31:435-443.
16. Haskins ME, Aguirre GD, Jezyk PF, et al. Animal model of human disease. Mucopolysaccharidosis type VII (Sly Syndrome) in the dog. Am J Pathol 1991;138:1553-1555.
17. Birkenmeier EH, Davisson MT, Beamer WG, et al. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest 1989;83:1258-1266.
18. Vogler C, Birkenmeier EH, Sly WS, et al. Murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Pathol 1990;136:207-217.
19. Sands MS, Birkenmeier EH. A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. Proc Natl Acad Sci U S A 1993;90:6567-6571.
20. Mollard RJ, Telegan P, Haskins ME, et al. Corneal endothelium in mucopolysaccharide storage disorders. Morphologic studies in animal models. Cornea 1996;15:25-34.
21. Haskins ME, Otis EJ, Hayden JE, et al. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidosis I, VI, and VII. Vet Pathol 1992;29:112-119.
22. Debenham SL, Millington A, Kijast J, et al. Canine leucocyte adhesion deficiency in Irish red and white setters. J Small Anim Pract 2002;43:74-75.
23. Giger U. Erythrocyte phosphofructokinase and pyruvate kinase deficiencies. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002;1020-1025.
24. Haskins ME, Desnick RJ, Diferrante N, et al. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII. Pediatr Res 1984;18:980-984.
25. Verdugo M, Salvetti A, Moullier P, et al. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro. Curr Eye Res 2001;23:357-367.
26. Wolfe JH, Sands MS, Harel N, et al. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII. Mol Ther 2000;2:552-561.
27. Wolfe JH, Taylor RM, Sands MS, et al. Mucopolysaccharidosis type VII as a model system for gene transfer to the central nervous system. Gene Ther 1994;1(suppl 1):S55.
28. Ray J, Wolfe JH, Aguirre GD, et al. Retroviral cDNA transfer to the RPE: stable expression and modification of metabolism. Invest Ophthalmol Vis Sci 1998;39:1658-1666.
29. Xu LF, Haskins ME, Melniczek JR, et al. Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs. Mol Ther 2002;5:141-153.